GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Shen Lian Biomedical Corp (SHSE:688098) » Definitions » PEG Ratio

Shanghai Shen Lian Biomedical (SHSE:688098) PEG Ratio : N/A (As of Jun. 08, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Shen Lian Biomedical PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Shanghai Shen Lian Biomedical's PE Ratio without NRI is 137.27. Shanghai Shen Lian Biomedical's 5-Year EBITDA growth rate is -2.90%. Therefore, Shanghai Shen Lian Biomedical's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Shanghai Shen Lian Biomedical's PEG Ratio or its related term are showing as below:


During the past 11 years, Shanghai Shen Lian Biomedical's highest PEG Ratio was 19.97. The lowest was 15.45. And the median was 16.82.


SHSE:688098's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.52
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Shanghai Shen Lian Biomedical PEG Ratio Historical Data

The historical data trend for Shanghai Shen Lian Biomedical's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shen Lian Biomedical PEG Ratio Chart

Shanghai Shen Lian Biomedical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 21.10 - -

Shanghai Shen Lian Biomedical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Shanghai Shen Lian Biomedical's PEG Ratio

For the Biotechnology subindustry, Shanghai Shen Lian Biomedical's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Shen Lian Biomedical's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Shen Lian Biomedical's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Shen Lian Biomedical's PEG Ratio falls into.



Shanghai Shen Lian Biomedical PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Shanghai Shen Lian Biomedical's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=137.27272727273/-2.90
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Shanghai Shen Lian Biomedical  (SHSE:688098) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Shanghai Shen Lian Biomedical PEG Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Shen Lian Biomedical's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Shen Lian Biomedical (SHSE:688098) Business Description

Traded in Other Exchanges
N/A
Address
No. 48, Jiangchuan East Road, Minhang District, Shanghai, CHN, 200241
Shanghai Shen Lian Biomedical Corp is engaged in the development, production and sales of veterinary biological products.
Executives
Ma Gui Jun Core technical personnel
Gao Yan Chun senior management

Shanghai Shen Lian Biomedical (SHSE:688098) Headlines

No Headlines